Global Mebeverine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Mebeverine is a drug used to alleviate some of the symptoms of irritable bowel syndrome. It works by relaxing the muscles in and around the gut.
LPI (LP Information)' newest research report, the “Mebeverine Industry Forecast” looks at past sales and reviews total world Mebeverine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mebeverine sales for 2023 through 2029. With Mebeverine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mebeverine industry.
This Insight Report provides a comprehensive analysis of the global Mebeverine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mebeverine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mebeverine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mebeverine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mebeverine.
The global Mebeverine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mebeverine players cover Abbott, Mylan, Greville Investing Limited, Expanscience, Berlin Pharmaceutical, Eipico Pharmaceutical, Sopharma, USV Private Limited and Puren Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebeverine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Mebeverine market?
What factors are driving Mebeverine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mebeverine market opportunities vary by end market size?
How does Mebeverine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Mebeverine is a drug used to alleviate some of the symptoms of irritable bowel syndrome. It works by relaxing the muscles in and around the gut.
LPI (LP Information)' newest research report, the “Mebeverine Industry Forecast” looks at past sales and reviews total world Mebeverine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mebeverine sales for 2023 through 2029. With Mebeverine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mebeverine industry.
This Insight Report provides a comprehensive analysis of the global Mebeverine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mebeverine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mebeverine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mebeverine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mebeverine.
The global Mebeverine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mebeverine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mebeverine players cover Abbott, Mylan, Greville Investing Limited, Expanscience, Berlin Pharmaceutical, Eipico Pharmaceutical, Sopharma, USV Private Limited and Puren Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebeverine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Capsule
- Tablet
- Hospital
- Drug Store
- On-line
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Mylan
- Greville Investing Limited
- Expanscience
- Berlin Pharmaceutical
- Eipico Pharmaceutical
- Sopharma
- USV Private Limited
- Puren Pharma
- Pharco
- Swiss Pharm
- Dr. Reddy's
- Aurovitas Pharma
What is the 10-year outlook for the global Mebeverine market?
What factors are driving Mebeverine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mebeverine market opportunities vary by end market size?
How does Mebeverine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mebeverine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mebeverine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mebeverine by Country/Region, 2018, 2022 & 2029
2.2 Mebeverine Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Mebeverine Sales by Type
2.3.1 Global Mebeverine Sales Market Share by Type (2018-2023)
2.3.2 Global Mebeverine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mebeverine Sale Price by Type (2018-2023)
2.4 Mebeverine Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mebeverine Sales by Application
2.5.1 Global Mebeverine Sale Market Share by Application (2018-2023)
2.5.2 Global Mebeverine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mebeverine Sale Price by Application (2018-2023)
3 GLOBAL MEBEVERINE BY COMPANY
3.1 Global Mebeverine Breakdown Data by Company
3.1.1 Global Mebeverine Annual Sales by Company (2018-2023)
3.1.2 Global Mebeverine Sales Market Share by Company (2018-2023)
3.2 Global Mebeverine Annual Revenue by Company (2018-2023)
3.2.1 Global Mebeverine Revenue by Company (2018-2023)
3.2.2 Global Mebeverine Revenue Market Share by Company (2018-2023)
3.3 Global Mebeverine Sale Price by Company
3.4 Key Manufacturers Mebeverine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mebeverine Product Location Distribution
3.4.2 Players Mebeverine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEBEVERINE BY GEOGRAPHIC REGION
4.1 World Historic Mebeverine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mebeverine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mebeverine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mebeverine Market Size by Country/Region (2018-2023)
4.2.1 Global Mebeverine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mebeverine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mebeverine Sales Growth
4.4 APAC Mebeverine Sales Growth
4.5 Europe Mebeverine Sales Growth
4.6 Middle East & Africa Mebeverine Sales Growth
5 AMERICAS
5.1 Americas Mebeverine Sales by Country
5.1.1 Americas Mebeverine Sales by Country (2018-2023)
5.1.2 Americas Mebeverine Revenue by Country (2018-2023)
5.2 Americas Mebeverine Sales by Type
5.3 Americas Mebeverine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mebeverine Sales by Region
6.1.1 APAC Mebeverine Sales by Region (2018-2023)
6.1.2 APAC Mebeverine Revenue by Region (2018-2023)
6.2 APAC Mebeverine Sales by Type
6.3 APAC Mebeverine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mebeverine by Country
7.1.1 Europe Mebeverine Sales by Country (2018-2023)
7.1.2 Europe Mebeverine Revenue by Country (2018-2023)
7.2 Europe Mebeverine Sales by Type
7.3 Europe Mebeverine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mebeverine by Country
8.1.1 Middle East & Africa Mebeverine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mebeverine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mebeverine Sales by Type
8.3 Middle East & Africa Mebeverine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mebeverine
10.3 Manufacturing Process Analysis of Mebeverine
10.4 Industry Chain Structure of Mebeverine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mebeverine Distributors
11.3 Mebeverine Customer
12 WORLD FORECAST REVIEW FOR MEBEVERINE BY GEOGRAPHIC REGION
12.1 Global Mebeverine Market Size Forecast by Region
12.1.1 Global Mebeverine Forecast by Region (2024-2029)
12.1.2 Global Mebeverine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mebeverine Forecast by Type
12.7 Global Mebeverine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Mebeverine Product Portfolios and Specifications
13.1.3 Abbott Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Mebeverine Product Portfolios and Specifications
13.2.3 Mylan Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Greville Investing Limited
13.3.1 Greville Investing Limited Company Information
13.3.2 Greville Investing Limited Mebeverine Product Portfolios and Specifications
13.3.3 Greville Investing Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Greville Investing Limited Main Business Overview
13.3.5 Greville Investing Limited Latest Developments
13.4 Expanscience
13.4.1 Expanscience Company Information
13.4.2 Expanscience Mebeverine Product Portfolios and Specifications
13.4.3 Expanscience Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Expanscience Main Business Overview
13.4.5 Expanscience Latest Developments
13.5 Berlin Pharmaceutical
13.5.1 Berlin Pharmaceutical Company Information
13.5.2 Berlin Pharmaceutical Mebeverine Product Portfolios and Specifications
13.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Berlin Pharmaceutical Main Business Overview
13.5.5 Berlin Pharmaceutical Latest Developments
13.6 Eipico Pharmaceutical
13.6.1 Eipico Pharmaceutical Company Information
13.6.2 Eipico Pharmaceutical Mebeverine Product Portfolios and Specifications
13.6.3 Eipico Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eipico Pharmaceutical Main Business Overview
13.6.5 Eipico Pharmaceutical Latest Developments
13.7 Sopharma
13.7.1 Sopharma Company Information
13.7.2 Sopharma Mebeverine Product Portfolios and Specifications
13.7.3 Sopharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sopharma Main Business Overview
13.7.5 Sopharma Latest Developments
13.8 USV Private Limited
13.8.1 USV Private Limited Company Information
13.8.2 USV Private Limited Mebeverine Product Portfolios and Specifications
13.8.3 USV Private Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 USV Private Limited Main Business Overview
13.8.5 USV Private Limited Latest Developments
13.9 Puren Pharma
13.9.1 Puren Pharma Company Information
13.9.2 Puren Pharma Mebeverine Product Portfolios and Specifications
13.9.3 Puren Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Puren Pharma Main Business Overview
13.9.5 Puren Pharma Latest Developments
13.10 Pharco
13.10.1 Pharco Company Information
13.10.2 Pharco Mebeverine Product Portfolios and Specifications
13.10.3 Pharco Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pharco Main Business Overview
13.10.5 Pharco Latest Developments
13.11 Swiss Pharm
13.11.1 Swiss Pharm Company Information
13.11.2 Swiss Pharm Mebeverine Product Portfolios and Specifications
13.11.3 Swiss Pharm Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Swiss Pharm Main Business Overview
13.11.5 Swiss Pharm Latest Developments
13.12 Dr. Reddy's
13.12.1 Dr. Reddy's Company Information
13.12.2 Dr. Reddy's Mebeverine Product Portfolios and Specifications
13.12.3 Dr. Reddy's Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dr. Reddy's Main Business Overview
13.12.5 Dr. Reddy's Latest Developments
13.13 Aurovitas Pharma
13.13.1 Aurovitas Pharma Company Information
13.13.2 Aurovitas Pharma Mebeverine Product Portfolios and Specifications
13.13.3 Aurovitas Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurovitas Pharma Main Business Overview
13.13.5 Aurovitas Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mebeverine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mebeverine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mebeverine by Country/Region, 2018, 2022 & 2029
2.2 Mebeverine Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Mebeverine Sales by Type
2.3.1 Global Mebeverine Sales Market Share by Type (2018-2023)
2.3.2 Global Mebeverine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mebeverine Sale Price by Type (2018-2023)
2.4 Mebeverine Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mebeverine Sales by Application
2.5.1 Global Mebeverine Sale Market Share by Application (2018-2023)
2.5.2 Global Mebeverine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mebeverine Sale Price by Application (2018-2023)
3 GLOBAL MEBEVERINE BY COMPANY
3.1 Global Mebeverine Breakdown Data by Company
3.1.1 Global Mebeverine Annual Sales by Company (2018-2023)
3.1.2 Global Mebeverine Sales Market Share by Company (2018-2023)
3.2 Global Mebeverine Annual Revenue by Company (2018-2023)
3.2.1 Global Mebeverine Revenue by Company (2018-2023)
3.2.2 Global Mebeverine Revenue Market Share by Company (2018-2023)
3.3 Global Mebeverine Sale Price by Company
3.4 Key Manufacturers Mebeverine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mebeverine Product Location Distribution
3.4.2 Players Mebeverine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEBEVERINE BY GEOGRAPHIC REGION
4.1 World Historic Mebeverine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mebeverine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mebeverine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mebeverine Market Size by Country/Region (2018-2023)
4.2.1 Global Mebeverine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mebeverine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mebeverine Sales Growth
4.4 APAC Mebeverine Sales Growth
4.5 Europe Mebeverine Sales Growth
4.6 Middle East & Africa Mebeverine Sales Growth
5 AMERICAS
5.1 Americas Mebeverine Sales by Country
5.1.1 Americas Mebeverine Sales by Country (2018-2023)
5.1.2 Americas Mebeverine Revenue by Country (2018-2023)
5.2 Americas Mebeverine Sales by Type
5.3 Americas Mebeverine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mebeverine Sales by Region
6.1.1 APAC Mebeverine Sales by Region (2018-2023)
6.1.2 APAC Mebeverine Revenue by Region (2018-2023)
6.2 APAC Mebeverine Sales by Type
6.3 APAC Mebeverine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mebeverine by Country
7.1.1 Europe Mebeverine Sales by Country (2018-2023)
7.1.2 Europe Mebeverine Revenue by Country (2018-2023)
7.2 Europe Mebeverine Sales by Type
7.3 Europe Mebeverine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mebeverine by Country
8.1.1 Middle East & Africa Mebeverine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mebeverine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mebeverine Sales by Type
8.3 Middle East & Africa Mebeverine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mebeverine
10.3 Manufacturing Process Analysis of Mebeverine
10.4 Industry Chain Structure of Mebeverine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mebeverine Distributors
11.3 Mebeverine Customer
12 WORLD FORECAST REVIEW FOR MEBEVERINE BY GEOGRAPHIC REGION
12.1 Global Mebeverine Market Size Forecast by Region
12.1.1 Global Mebeverine Forecast by Region (2024-2029)
12.1.2 Global Mebeverine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mebeverine Forecast by Type
12.7 Global Mebeverine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Mebeverine Product Portfolios and Specifications
13.1.3 Abbott Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Mebeverine Product Portfolios and Specifications
13.2.3 Mylan Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Greville Investing Limited
13.3.1 Greville Investing Limited Company Information
13.3.2 Greville Investing Limited Mebeverine Product Portfolios and Specifications
13.3.3 Greville Investing Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Greville Investing Limited Main Business Overview
13.3.5 Greville Investing Limited Latest Developments
13.4 Expanscience
13.4.1 Expanscience Company Information
13.4.2 Expanscience Mebeverine Product Portfolios and Specifications
13.4.3 Expanscience Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Expanscience Main Business Overview
13.4.5 Expanscience Latest Developments
13.5 Berlin Pharmaceutical
13.5.1 Berlin Pharmaceutical Company Information
13.5.2 Berlin Pharmaceutical Mebeverine Product Portfolios and Specifications
13.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Berlin Pharmaceutical Main Business Overview
13.5.5 Berlin Pharmaceutical Latest Developments
13.6 Eipico Pharmaceutical
13.6.1 Eipico Pharmaceutical Company Information
13.6.2 Eipico Pharmaceutical Mebeverine Product Portfolios and Specifications
13.6.3 Eipico Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eipico Pharmaceutical Main Business Overview
13.6.5 Eipico Pharmaceutical Latest Developments
13.7 Sopharma
13.7.1 Sopharma Company Information
13.7.2 Sopharma Mebeverine Product Portfolios and Specifications
13.7.3 Sopharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sopharma Main Business Overview
13.7.5 Sopharma Latest Developments
13.8 USV Private Limited
13.8.1 USV Private Limited Company Information
13.8.2 USV Private Limited Mebeverine Product Portfolios and Specifications
13.8.3 USV Private Limited Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 USV Private Limited Main Business Overview
13.8.5 USV Private Limited Latest Developments
13.9 Puren Pharma
13.9.1 Puren Pharma Company Information
13.9.2 Puren Pharma Mebeverine Product Portfolios and Specifications
13.9.3 Puren Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Puren Pharma Main Business Overview
13.9.5 Puren Pharma Latest Developments
13.10 Pharco
13.10.1 Pharco Company Information
13.10.2 Pharco Mebeverine Product Portfolios and Specifications
13.10.3 Pharco Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pharco Main Business Overview
13.10.5 Pharco Latest Developments
13.11 Swiss Pharm
13.11.1 Swiss Pharm Company Information
13.11.2 Swiss Pharm Mebeverine Product Portfolios and Specifications
13.11.3 Swiss Pharm Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Swiss Pharm Main Business Overview
13.11.5 Swiss Pharm Latest Developments
13.12 Dr. Reddy's
13.12.1 Dr. Reddy's Company Information
13.12.2 Dr. Reddy's Mebeverine Product Portfolios and Specifications
13.12.3 Dr. Reddy's Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dr. Reddy's Main Business Overview
13.12.5 Dr. Reddy's Latest Developments
13.13 Aurovitas Pharma
13.13.1 Aurovitas Pharma Company Information
13.13.2 Aurovitas Pharma Mebeverine Product Portfolios and Specifications
13.13.3 Aurovitas Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurovitas Pharma Main Business Overview
13.13.5 Aurovitas Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mebeverine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mebeverine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Global Mebeverine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mebeverine Sales Market Share by Type (2018-2023)
Table 7. Global Mebeverine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mebeverine Revenue Market Share by Type (2018-2023)
Table 9. Global Mebeverine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mebeverine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mebeverine Sales Market Share by Application (2018-2023)
Table 12. Global Mebeverine Revenue by Application (2018-2023)
Table 13. Global Mebeverine Revenue Market Share by Application (2018-2023)
Table 14. Global Mebeverine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mebeverine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mebeverine Sales Market Share by Company (2018-2023)
Table 17. Global Mebeverine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mebeverine Revenue Market Share by Company (2018-2023)
Table 19. Global Mebeverine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mebeverine Producing Area Distribution and Sales Area
Table 21. Players Mebeverine Products Offered
Table 22. Mebeverine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mebeverine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mebeverine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mebeverine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mebeverine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mebeverine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mebeverine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mebeverine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mebeverine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mebeverine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mebeverine Sales Market Share by Country (2018-2023)
Table 35. Americas Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mebeverine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mebeverine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mebeverine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mebeverine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mebeverine Sales Market Share by Region (2018-2023)
Table 41. APAC Mebeverine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mebeverine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mebeverine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mebeverine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mebeverine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mebeverine Sales Market Share by Country (2018-2023)
Table 47. Europe Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mebeverine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mebeverine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mebeverine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mebeverine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mebeverine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mebeverine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mebeverine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mebeverine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mebeverine
Table 58. Key Market Challenges & Risks of Mebeverine
Table 59. Key Industry Trends of Mebeverine
Table 60. Mebeverine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mebeverine Distributors List
Table 63. Mebeverine Customer List
Table 64. Global Mebeverine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mebeverine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mebeverine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mebeverine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mebeverine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mebeverine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mebeverine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mebeverine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Mebeverine Product Portfolios and Specifications
Table 80. Abbott Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Mylan Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Mebeverine Product Portfolios and Specifications
Table 85. Mylan Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. Greville Investing Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 89. Greville Investing Limited Mebeverine Product Portfolios and Specifications
Table 90. Greville Investing Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Greville Investing Limited Main Business
Table 92. Greville Investing Limited Latest Developments
Table 93. Expanscience Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 94. Expanscience Mebeverine Product Portfolios and Specifications
Table 95. Expanscience Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Expanscience Main Business
Table 97. Expanscience Latest Developments
Table 98. Berlin Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 99. Berlin Pharmaceutical Mebeverine Product Portfolios and Specifications
Table 100. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Berlin Pharmaceutical Main Business
Table 102. Berlin Pharmaceutical Latest Developments
Table 103. Eipico Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 104. Eipico Pharmaceutical Mebeverine Product Portfolios and Specifications
Table 105. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Eipico Pharmaceutical Main Business
Table 107. Eipico Pharmaceutical Latest Developments
Table 108. Sopharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sopharma Mebeverine Product Portfolios and Specifications
Table 110. Sopharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sopharma Main Business
Table 112. Sopharma Latest Developments
Table 113. USV Private Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 114. USV Private Limited Mebeverine Product Portfolios and Specifications
Table 115. USV Private Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. USV Private Limited Main Business
Table 117. USV Private Limited Latest Developments
Table 118. Puren Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 119. Puren Pharma Mebeverine Product Portfolios and Specifications
Table 120. Puren Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Puren Pharma Main Business
Table 122. Puren Pharma Latest Developments
Table 123. Pharco Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 124. Pharco Mebeverine Product Portfolios and Specifications
Table 125. Pharco Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Pharco Main Business
Table 127. Pharco Latest Developments
Table 128. Swiss Pharm Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 129. Swiss Pharm Mebeverine Product Portfolios and Specifications
Table 130. Swiss Pharm Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Swiss Pharm Main Business
Table 132. Swiss Pharm Latest Developments
Table 133. Dr. Reddy's Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dr. Reddy's Mebeverine Product Portfolios and Specifications
Table 135. Dr. Reddy's Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dr. Reddy's Main Business
Table 137. Dr. Reddy's Latest Developments
Table 138. Aurovitas Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 139. Aurovitas Pharma Mebeverine Product Portfolios and Specifications
Table 140. Aurovitas Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Aurovitas Pharma Main Business
Table 142. Aurovitas Pharma Latest Developments
Table 1. Mebeverine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mebeverine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Global Mebeverine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mebeverine Sales Market Share by Type (2018-2023)
Table 7. Global Mebeverine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mebeverine Revenue Market Share by Type (2018-2023)
Table 9. Global Mebeverine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mebeverine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mebeverine Sales Market Share by Application (2018-2023)
Table 12. Global Mebeverine Revenue by Application (2018-2023)
Table 13. Global Mebeverine Revenue Market Share by Application (2018-2023)
Table 14. Global Mebeverine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mebeverine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mebeverine Sales Market Share by Company (2018-2023)
Table 17. Global Mebeverine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mebeverine Revenue Market Share by Company (2018-2023)
Table 19. Global Mebeverine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mebeverine Producing Area Distribution and Sales Area
Table 21. Players Mebeverine Products Offered
Table 22. Mebeverine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mebeverine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mebeverine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mebeverine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mebeverine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mebeverine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mebeverine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mebeverine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mebeverine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mebeverine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mebeverine Sales Market Share by Country (2018-2023)
Table 35. Americas Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mebeverine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mebeverine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mebeverine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mebeverine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mebeverine Sales Market Share by Region (2018-2023)
Table 41. APAC Mebeverine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mebeverine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mebeverine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mebeverine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mebeverine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mebeverine Sales Market Share by Country (2018-2023)
Table 47. Europe Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mebeverine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mebeverine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mebeverine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mebeverine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mebeverine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mebeverine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mebeverine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mebeverine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mebeverine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mebeverine
Table 58. Key Market Challenges & Risks of Mebeverine
Table 59. Key Industry Trends of Mebeverine
Table 60. Mebeverine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mebeverine Distributors List
Table 63. Mebeverine Customer List
Table 64. Global Mebeverine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mebeverine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mebeverine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mebeverine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mebeverine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mebeverine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mebeverine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mebeverine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mebeverine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mebeverine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Mebeverine Product Portfolios and Specifications
Table 80. Abbott Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Mylan Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Mebeverine Product Portfolios and Specifications
Table 85. Mylan Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. Greville Investing Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 89. Greville Investing Limited Mebeverine Product Portfolios and Specifications
Table 90. Greville Investing Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Greville Investing Limited Main Business
Table 92. Greville Investing Limited Latest Developments
Table 93. Expanscience Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 94. Expanscience Mebeverine Product Portfolios and Specifications
Table 95. Expanscience Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Expanscience Main Business
Table 97. Expanscience Latest Developments
Table 98. Berlin Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 99. Berlin Pharmaceutical Mebeverine Product Portfolios and Specifications
Table 100. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Berlin Pharmaceutical Main Business
Table 102. Berlin Pharmaceutical Latest Developments
Table 103. Eipico Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 104. Eipico Pharmaceutical Mebeverine Product Portfolios and Specifications
Table 105. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Eipico Pharmaceutical Main Business
Table 107. Eipico Pharmaceutical Latest Developments
Table 108. Sopharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sopharma Mebeverine Product Portfolios and Specifications
Table 110. Sopharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sopharma Main Business
Table 112. Sopharma Latest Developments
Table 113. USV Private Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 114. USV Private Limited Mebeverine Product Portfolios and Specifications
Table 115. USV Private Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. USV Private Limited Main Business
Table 117. USV Private Limited Latest Developments
Table 118. Puren Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 119. Puren Pharma Mebeverine Product Portfolios and Specifications
Table 120. Puren Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Puren Pharma Main Business
Table 122. Puren Pharma Latest Developments
Table 123. Pharco Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 124. Pharco Mebeverine Product Portfolios and Specifications
Table 125. Pharco Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Pharco Main Business
Table 127. Pharco Latest Developments
Table 128. Swiss Pharm Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 129. Swiss Pharm Mebeverine Product Portfolios and Specifications
Table 130. Swiss Pharm Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Swiss Pharm Main Business
Table 132. Swiss Pharm Latest Developments
Table 133. Dr. Reddy's Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dr. Reddy's Mebeverine Product Portfolios and Specifications
Table 135. Dr. Reddy's Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dr. Reddy's Main Business
Table 137. Dr. Reddy's Latest Developments
Table 138. Aurovitas Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 139. Aurovitas Pharma Mebeverine Product Portfolios and Specifications
Table 140. Aurovitas Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Aurovitas Pharma Main Business
Table 142. Aurovitas Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mebeverine
Figure 2. Mebeverine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mebeverine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mebeverine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mebeverine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Mebeverine Sales Market Share by Type in 2022
Figure 12. Global Mebeverine Revenue Market Share by Type (2018-2023)
Figure 13. Mebeverine Consumed in Hospital
Figure 14. Global Mebeverine Market: Hospital (2018-2023) & (K Units)
Figure 15. Mebeverine Consumed in Drug Store
Figure 16. Global Mebeverine Market: Drug Store (2018-2023) & (K Units)
Figure 17. Mebeverine Consumed in On-line
Figure 18. Global Mebeverine Market: On-line (2018-2023) & (K Units)
Figure 19. Global Mebeverine Sales Market Share by Application (2022)
Figure 20. Global Mebeverine Revenue Market Share by Application in 2022
Figure 21. Mebeverine Sales Market by Company in 2022 (K Units)
Figure 22. Global Mebeverine Sales Market Share by Company in 2022
Figure 23. Mebeverine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mebeverine Revenue Market Share by Company in 2022
Figure 25. Global Mebeverine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mebeverine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mebeverine Sales 2018-2023 (K Units)
Figure 28. Americas Mebeverine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mebeverine Sales 2018-2023 (K Units)
Figure 30. APAC Mebeverine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mebeverine Sales 2018-2023 (K Units)
Figure 32. Europe Mebeverine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mebeverine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mebeverine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mebeverine Sales Market Share by Country in 2022
Figure 36. Americas Mebeverine Revenue Market Share by Country in 2022
Figure 37. Americas Mebeverine Sales Market Share by Type (2018-2023)
Figure 38. Americas Mebeverine Sales Market Share by Application (2018-2023)
Figure 39. United States Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mebeverine Sales Market Share by Region in 2022
Figure 44. APAC Mebeverine Revenue Market Share by Regions in 2022
Figure 45. APAC Mebeverine Sales Market Share by Type (2018-2023)
Figure 46. APAC Mebeverine Sales Market Share by Application (2018-2023)
Figure 47. China Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mebeverine Sales Market Share by Country in 2022
Figure 55. Europe Mebeverine Revenue Market Share by Country in 2022
Figure 56. Europe Mebeverine Sales Market Share by Type (2018-2023)
Figure 57. Europe Mebeverine Sales Market Share by Application (2018-2023)
Figure 58. Germany Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mebeverine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mebeverine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mebeverine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mebeverine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mebeverine in 2022
Figure 73. Manufacturing Process Analysis of Mebeverine
Figure 74. Industry Chain Structure of Mebeverine
Figure 75. Channels of Distribution
Figure 76. Global Mebeverine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mebeverine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mebeverine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mebeverine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mebeverine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mebeverine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Mebeverine
Figure 2. Mebeverine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mebeverine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mebeverine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mebeverine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Mebeverine Sales Market Share by Type in 2022
Figure 12. Global Mebeverine Revenue Market Share by Type (2018-2023)
Figure 13. Mebeverine Consumed in Hospital
Figure 14. Global Mebeverine Market: Hospital (2018-2023) & (K Units)
Figure 15. Mebeverine Consumed in Drug Store
Figure 16. Global Mebeverine Market: Drug Store (2018-2023) & (K Units)
Figure 17. Mebeverine Consumed in On-line
Figure 18. Global Mebeverine Market: On-line (2018-2023) & (K Units)
Figure 19. Global Mebeverine Sales Market Share by Application (2022)
Figure 20. Global Mebeverine Revenue Market Share by Application in 2022
Figure 21. Mebeverine Sales Market by Company in 2022 (K Units)
Figure 22. Global Mebeverine Sales Market Share by Company in 2022
Figure 23. Mebeverine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mebeverine Revenue Market Share by Company in 2022
Figure 25. Global Mebeverine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mebeverine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mebeverine Sales 2018-2023 (K Units)
Figure 28. Americas Mebeverine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mebeverine Sales 2018-2023 (K Units)
Figure 30. APAC Mebeverine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mebeverine Sales 2018-2023 (K Units)
Figure 32. Europe Mebeverine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mebeverine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mebeverine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mebeverine Sales Market Share by Country in 2022
Figure 36. Americas Mebeverine Revenue Market Share by Country in 2022
Figure 37. Americas Mebeverine Sales Market Share by Type (2018-2023)
Figure 38. Americas Mebeverine Sales Market Share by Application (2018-2023)
Figure 39. United States Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mebeverine Sales Market Share by Region in 2022
Figure 44. APAC Mebeverine Revenue Market Share by Regions in 2022
Figure 45. APAC Mebeverine Sales Market Share by Type (2018-2023)
Figure 46. APAC Mebeverine Sales Market Share by Application (2018-2023)
Figure 47. China Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mebeverine Sales Market Share by Country in 2022
Figure 55. Europe Mebeverine Revenue Market Share by Country in 2022
Figure 56. Europe Mebeverine Sales Market Share by Type (2018-2023)
Figure 57. Europe Mebeverine Sales Market Share by Application (2018-2023)
Figure 58. Germany Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mebeverine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mebeverine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mebeverine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mebeverine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mebeverine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mebeverine in 2022
Figure 73. Manufacturing Process Analysis of Mebeverine
Figure 74. Industry Chain Structure of Mebeverine
Figure 75. Channels of Distribution
Figure 76. Global Mebeverine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mebeverine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mebeverine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mebeverine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mebeverine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mebeverine Revenue Market Share Forecast by Application (2024-2029)
